Aston Group's efforts in gynaecology are largely focused on cancer studies, although some other disorders have been explored.
In the recent years, Aston Group has conducted several marketing studies on the treatment of endometriosis, uterine fibroid and infertility.
We have researched such aspects as threatened preterm labour, heavy bleeding in labour, and the use of hormonal and non-hormonal contraceptives.
In 2011, Aston participated in developing and launching the Registry of Congenital Malformations of Female Reproductive Organs. The studies have covered 300 clinics across the country (inpatient and outpatient facilities, female counselling centres and maternity clinics).